Literature DB >> 21280156

Krüppel-like family of transcription factor 9, a differentiation-associated transcription factor, suppresses Notch1 signaling and inhibits glioblastoma-initiating stem cells.

Mingyao Ying1, Yingying Sang, Yunqing Li, Hugo Guerrero-Cazares, Alfredo Quinones-Hinojosa, Angelo L Vescovi, Charles G Eberhart, Shuli Xia, John Laterra.   

Abstract

Tumor-initiating stem cells (alternatively called cancer stem cells, CSCs) are a subpopulation of tumor cells that plays unique roles in tumor propagation, therapeutic resistance, and tumor recurrence. It is becoming increasingly important to understand the molecular signaling that regulates the self-renewal and differentiation of CSCs. Transcription factors are critical for the regulation of normal and neopolastic stem cells. Here, we examined the expression and function of the Krüppel-like family of transcription factors (KLFs) in human glioblastoma (GBM)-derived neurosphere lines and low-passage primary GBM-derived neurospheres that are enriched for tumor-initiating stem cells. We identify KLF9 as a relatively unique differentiation-induced transcription factor in GBM-derived neurospheres. KLF9 is shown to induce neurosphere cell differentiation, inhibit neurosphere formation, and inhibit neurosphere-derived xenograft growth in vivo. We also show that KLF9 regulates GBM neurosphere cells by binding to the Notch1 promoter and suppressing Notch1 expression and downstream signaling. Our results show for the first time that KLF9 has differentiating and tumor-suppressing functions in tumor-initiating stem cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21280156      PMCID: PMC3516843          DOI: 10.1002/stem.561

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  67 in total

1.  Core transcriptional regulatory circuitry in human embryonic stem cells.

Authors:  Laurie A Boyer; Tong Ihn Lee; Megan F Cole; Sarah E Johnstone; Stuart S Levine; Jacob P Zucker; Matthew G Guenther; Roshan M Kumar; Heather L Murray; Richard G Jenner; David K Gifford; Douglas A Melton; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

Review 2.  Brain tumour stem cells.

Authors:  Angelo L Vescovi; Rossella Galli; Brent A Reynolds
Journal:  Nat Rev Cancer       Date:  2006-06       Impact factor: 60.716

3.  Notch signalling regulates stem cell numbers in vitro and in vivo.

Authors:  Andreas Androutsellis-Theotokis; Ronen R Leker; Frank Soldner; Daniel J Hoeppner; Rea Ravin; Steve W Poser; Maria A Rueger; Soo-Kyung Bae; Raja Kittappa; Ronald D G McKay
Journal:  Nature       Date:  2006-06-25       Impact factor: 49.962

4.  Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor.

Authors:  Shideng Bao; Qiulian Wu; Sith Sathornsumetee; Yueling Hao; Zhizhong Li; Anita B Hjelmeland; Qing Shi; Roger E McLendon; Darell D Bigner; Jeremy N Rich
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701

5.  Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.

Authors:  Shideng Bao; Qiulian Wu; Roger E McLendon; Yueling Hao; Qing Shi; Anita B Hjelmeland; Mark W Dewhirst; Darell D Bigner; Jeremy N Rich
Journal:  Nature       Date:  2006-10-18       Impact factor: 49.962

6.  The KLF4 tumour suppressor is a transcriptional repressor of p53 that acts as a context-dependent oncogene.

Authors:  Benjamin D Rowland; René Bernards; Daniel S Peeper
Journal:  Nat Cell Biol       Date:  2005-11       Impact factor: 28.824

7.  Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines.

Authors:  Jeongwu Lee; Svetlana Kotliarova; Yuri Kotliarov; Aiguo Li; Qin Su; Nicholas M Donin; Sandra Pastorino; Benjamin W Purow; Neil Christopher; Wei Zhang; John K Park; Howard A Fine
Journal:  Cancer Cell       Date:  2006-05       Impact factor: 31.743

8.  Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.

Authors:  Kazutoshi Takahashi; Shinya Yamanaka
Journal:  Cell       Date:  2006-08-10       Impact factor: 41.582

9.  Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.

Authors:  S G M Piccirillo; B A Reynolds; N Zanetti; G Lamorte; E Binda; G Broggi; H Brem; A Olivi; F Dimeco; A L Vescovi
Journal:  Nature       Date:  2006-12-07       Impact factor: 49.962

Review 10.  Notch signalling: a simple pathway becomes complex.

Authors:  Sarah J Bray
Journal:  Nat Rev Mol Cell Biol       Date:  2006-09       Impact factor: 94.444

View more
  43 in total

1.  KLF9 is a novel transcriptional regulator of bortezomib- and LBH589-induced apoptosis in multiple myeloma cells.

Authors:  Sudha Mannava; DaZhong Zhuang; Jayakumar R Nair; Rajat Bansal; Joseph A Wawrzyniak; Shoshanna N Zucker; Emily E Fink; Kalyana C Moparthy; Qiang Hu; Song Liu; Lawrence H Boise; Kelvin P Lee; Mikhail A Nikiforov
Journal:  Blood       Date:  2011-12-05       Impact factor: 22.113

Review 2.  Krüppel-like factors in cancer.

Authors:  Marie-Pier Tetreault; Yizeng Yang; Jonathan P Katz
Journal:  Nat Rev Cancer       Date:  2013-10       Impact factor: 60.716

3.  MicroRNA-570 promotes lung carcinoma proliferation through targeting tumor suppressor KLF9.

Authors:  Xiang-Dong Tong; Tie-Qin Liu; Ge-Bang Wang; Chen-Lei Zhang; Hong-Xu Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

4.  Non-virally engineered human adipose mesenchymal stem cells produce BMP4, target brain tumors, and extend survival.

Authors:  Antonella Mangraviti; Stephany Y Tzeng; David Gullotti; Kristen L Kozielski; Jennifer E Kim; Michael Seng; Sara Abbadi; Paula Schiapparelli; Rachel Sarabia-Estrada; Angelo Vescovi; Henry Brem; Alessandro Olivi; Betty Tyler; Jordan J Green; Alfredo Quinones-Hinojosa
Journal:  Biomaterials       Date:  2016-05-21       Impact factor: 12.479

5.  The T3-induced gene KLF9 regulates oligodendrocyte differentiation and myelin regeneration.

Authors:  Jason C Dugas; Adiljan Ibrahim; Ben A Barres
Journal:  Mol Cell Neurosci       Date:  2012-03-24       Impact factor: 4.314

6.  Regulation of glioblastoma multiforme stem-like cells by inhibitor of DNA binding proteins and oligodendroglial lineage-associated transcription factors.

Authors:  Yanjue Wu; Jean-Philippe Richard; Shervin D Wang; Prakash Rath; John Laterra; Shuli Xia
Journal:  Cancer Sci       Date:  2012-04-04       Impact factor: 6.716

Review 7.  Krüpple-like factors in the central nervous system: novel mediators in stroke.

Authors:  Ke-Jie Yin; Milton Hamblin; Yanbo Fan; Jifeng Zhang; Y Eugene Chen
Journal:  Metab Brain Dis       Date:  2013-12-15       Impact factor: 3.584

8.  Effect of bexarotene on differentiation of glioblastoma multiforme compared with ATRA.

Authors:  Jin-Chul Heo; Tae-Hoon Jung; Sungjin Lee; Hyun Young Kim; Gildon Choi; Myungeun Jung; Daeyoung Jung; Heung Kyoung Lee; Jung-Ok Lee; Ji-Hwan Park; Daehee Hwang; Ho Jun Seol; Heeyeong Cho
Journal:  Clin Exp Metastasis       Date:  2016-03-08       Impact factor: 5.150

9.  Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.

Authors:  Shuli Xia; Bachchu Lal; Brian Tung; Shervin Wang; C Rory Goodwin; John Laterra
Journal:  Neuro Oncol       Date:  2015-08-27       Impact factor: 12.300

10.  Krüppel-like factor 9 (KLF9) prevents colorectal cancer through inhibition of interferon-related signaling.

Authors:  Adam R Brown; Rosalia C M Simmen; Vinay R Raj; Trang T Van; Stewart L MacLeod; Frank A Simmen
Journal:  Carcinogenesis       Date:  2015-07-25       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.